Difference between revisions of "CLMAT3"

From LncRNAWiki
Jump to: navigation, search
Line 23: Line 23:
 
===Expression---
 
===Expression---
 
The levels of CLMAT3 in the cancerous tissues were 2.26-fold higher than those in the normal colorectal tissues (P<0.05). In addition, CLMAT3 expression was significantly higher in the patients with liver metastasis than in those without liver metastasis and in the patients with lymph node metastasis than in those without lymph node metastasis.<ref name="ref1" />
 
The levels of CLMAT3 in the cancerous tissues were 2.26-fold higher than those in the normal colorectal tissues (P<0.05). In addition, CLMAT3 expression was significantly higher in the patients with liver metastasis than in those without liver metastasis and in the patients with lymph node metastasis than in those without lymph node metastasis.<ref name="ref1" />
 +
 +
==Labs working on this lncRNA==
 +
* Department of Oncological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.<ref name="ref1" />
 +
* Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200000, People's Republic of China.<ref name="ref1" />
 +
 +
==References==
 +
<references>
 +
<ref name="ref1"> Ye, L.C., et al., Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Tumour Biol, 2015. 36(11): p. 8747-54.
 +
</ref>(1)
 +
</references>

Revision as of 06:33, 26 November 2017

Annotated Information

Approved Symbol

CLMAT3

Approved Name

colorectal liver metastasis associated transcript 3

Synonyms

SPARC-AS1

Chromosome

5q33.1

RefSeq(supplied by NCBI)

NR_109873

The CLMAT3 expression levels in 90 paired CRC and normal tissue samples were analyzed via a qRT-PCR assay[1]

pubmed IDs

26050227

Disease

colorectal cancer

Characteristics

lncRNA-CLMAT3 is located on human chromosome 14 (chr14:101379770-101381326, hg19).

Function

The patients with tumors displaying high CLMAT3 expression exhibited shorter OS than the patients with tumors displaying low CLMAT3 expression. [1] Colorectal cancer patients displaying high expression levels of CLMAT3 more frequently developed liver metastases than those with low lncRNA-CLMAT3 expression levels, indicating that lncRNA-CLMAT3 may act as an oncogene.[1]

===Expression--- The levels of CLMAT3 in the cancerous tissues were 2.26-fold higher than those in the normal colorectal tissues (P<0.05). In addition, CLMAT3 expression was significantly higher in the patients with liver metastasis than in those without liver metastasis and in the patients with lymph node metastasis than in those without lymph node metastasis.[1]

Labs working on this lncRNA

  • Department of Oncological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.[1]
  • Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200000, People's Republic of China.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Ye, L.C., et al., Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis. Tumour Biol, 2015. 36(11): p. 8747-54.